ALEXANDRA (ANDRA) NICHOLSON, PhD

Director, Research Partnerships

As Bluefield’s Director of Research Partnerships, Dr. Nicholson develops and manages ongoing collaborations with academic and industry stakeholders, aggressively moving projects forward to support therapeutic development. With her extensive background in FTD research, Dr. Nicholson provides deep expertise in the biology of progranulin and other FTD-linked molecules.

Dr. Nicholson earned a B.S. in biochemistry from Beloit College and a Ph.D. in cellular neuroscience from Northwestern University, where she studied the molecular mechanisms of Alzheimer's disease. After completing her Ph.D., Dr. Nicholson continued in academic research at Mayo Clinic Jacksonville, authoring or co-authoring 20 papers on the genetic and cellular contributions to FTD during her postdoctoral studies. She joined Bluefield in 2017.